pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
fda recalls·Aug 14·1 min read
save

Exotique Foods recalls Momchipz Veggie Chips over undeclared wheat risk

Aug 14, 2026·read at fda recalls ↗CRLNegative

Exotique Foods Inc announced a recall of its Momchipz Veggie Chips Broccoli Florets & Cauliflower because the product may contain undeclared wheat, posing a serious allergy risk.

The chips, sold to 49 US customers through Amazon between March and June 2026, were originally listed with a best-by date of August 31, 2026. An update on August 24 clarified that the allergen is wheat, not gluten.

Consumers with wheat allergy or severe sensitivity are advised to discard the product or return it for a full refund. No illnesses have been reported so far.

source

This writeup was produced by pharmadog from original reporting by fda recalls.

Original headline: “Exotique Foods Inc Recalls Momchipz Veggie Chips Broccoli Florets & Cauliflower Due to Undeclared Wheat”

read at fda recalls ↗
254 words · retrieved 5h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Recall4

related stories

  • Jul 21Biotech industry leaders file brief backing FDA against ‘malicious’ mifepristone challengeFierce Biotech
  • Jul 21STAT+: Pharmalittle: We’re reading about Novo suing Lilly over ‘deceptive’ ads, a fugitive’s secret life in biotech, and moreSTAT
  • Jul 21A renewed push from the right against abortion pillsSTAT
  • Jul 20FDA still focused on lettuce supplier as source of parasite, despite faulty test resultSTAT
  • Jul 17STAT+: Pharmalittle: We’re reading about rising drug shortages, GSK coughing up a trial loss, and moreSTAT